Amneal Pharmaceuticals Inc (NYSE:AMRX)

5.20
Delayed Data
As of Jun 18
 -0.36 / -6.47%
Today’s Change
3.45
Today|||52-Week Range
7.45
+13.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues476.5M497.5M446.1M404.6M
 
 
 
 
 
Cost of Goods Sold233.4M256.6M260.9M245.7M
 
 
 
 
 
Depreciation And Amortization43.0M47.5M48.9M50.7M
 
 
 
 
 
 
Operating ExpensesGross Income200.1M193.4M136.4M108.3M
 
 
 
 
 
General Expenses121.1M128.5M138.3M115.3M
 
 
 
 
 
Research And Development43.0M57.3M53.9M48.0M
 
 
 
 
 
Total Operating Expenses397.5M432.7M448.0M411.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income79.0M64.9M-1.9M-7.0M
 
 
 
 
 
Extraordinary Credit0.0016.1M0.000.00
 
 
Extraordinary Charge-4.5M-57.7M-92.4M-11.9M
 
 
 
 
 
Interest Expense On Debt43.0M42.9M43.3M43.9M
 
 
 
 
 
Other Expenses-9.0M4.8M4.5M6.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income22.6M-14.8M-133.2M-56.2M
 
 
 
 
 
Income Taxes-5.1M-5.5M-8.4M-5.7M
 
 
 
 
 
Minority Interest-10.5M-11.6M-76.9M-33.6M
 
 
 
 
 
Net Income7.0M-8.8M-47.9M-16.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS127.2M127.3M127.7M128.0M
 
 
 
 
 
Shares To Calculate EPS Diluted128.2M127.3M127.7M128.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.05-$0.07-$0.38-$0.13
 
 
 
 
 
EPS Diluted$0.05-$0.07-$0.38-$0.13